acute myeloid leukemia

Showing NaN - NaN of 68

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-500)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Los Angeles, California
  • +9 more
Jun 27, 2023

Acute Myeloid Leukemia Trial in Los Angeles, San Francisco (Azacitidine, Tagraxofusp-erzs)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +1 more
Jan 31, 2023

Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia

Active, not recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Birmingham, Alabama
  • +190 more
Jan 30, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Los Angeles, California
  • +5 more
Jan 27, 2023

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (Orca-T,

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • Orca-T
  • Standard-of-Care
  • Duarte, California
  • +13 more
Jan 25, 2023

Acute Myeloid Leukemia, MDS Trial in United States (SL-172154)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +12 more
Jan 23, 2023

Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia Trial in United States (TTI-622, Azacitidine, Venetoclax)

Recruiting
  • Lymphoma
  • +3 more
  • Los Angeles, California
  • +36 more
Jan 23, 2023

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Zilovertamab vedotin
  • Duarte, California
  • +13 more
Jan 12, 2023

Acute Myeloid Leukemia Trial in Canada, United States (Clinical Observation, Laboratory Biomarker Analysis, Nivolumab)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Clinical Observation
  • +2 more
  • Birmingham, Alabama
  • +45 more
Dec 30, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Trial in United States

Suspended
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • Los Angeles, California
  • +5 more
Dec 10, 2022

Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +43 more
Nov 17, 2022

Acute Myeloid Leukemia Trial in United Kingdom, United States (Arm 1: NTLA-5001, Arm 2: NTLA-5001)

Terminated
  • Acute Myeloid Leukemia
  • Arm 1: NTLA-5001
  • Arm 2: NTLA-5001
  • Los Angeles, California
  • +9 more
Oct 13, 2022

Acute Myeloid Leukemia, Stem Cell Transplantation Trial in United States (MT-401)

Recruiting
  • Acute Myeloid Leukemia
  • Stem Cell Transplantation
  • Birmingham, Alabama
  • +15 more
Aug 22, 2022

Acute Myeloid Leukemia Trial in United States (Cytarabine, Daunorubicin, Uproleselan)

Suspended
  • Acute Myeloid Leukemia
  • Little Rock, Arkansas
  • +187 more
Aug 17, 2022

Acute Myeloid Leukemia Trial in Worldwide (TL-895, KRT-232)

Recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +33 more
Aug 3, 2022

Collecting and Storing Tissue From Young Patients With Cancer

Recruiting
  • Acute Lymphoblastic Leukemia
  • +13 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +68 more
Aug 4, 2022

Acute Myeloid Leukemia Trial in Canada, Spain, United States (Decitabine and Cedazuridine (ASTX727), Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +15 more
Jul 29, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-219)

Recruiting
  • Acute Myeloid Leukemia
  • +12 more
  • Los Angeles, California
  • +6 more
Jun 1, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Worldwide (biological, drug, procedure)

Terminated
  • Acute Myeloid Leukemia
  • +2 more
  • ATIR101
  • +3 more
  • Duarte, California
  • +41 more
Apr 28, 2022

Acute Myeloid Leukemia Trial in United States (Quizartinib, Milademetan)

Terminated
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +7 more
Mar 14, 2022

Acute Myeloid Leukemia Trial in Canada, Puerto Rico, United States (procedure, drug, behavioral)

Recruiting
  • Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +13 more
  • Birmingham, Alabama
  • +187 more
Apr 28, 2022

Acute Myeloid Leukemia Trial in Worldwide (Alvocidib, Cytarabine, Mitoxantrone)

Terminated
  • Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +37 more
Apr 4, 2022

Acute Myeloid Leukemia Trial in Worldwide (Uproleselan, Placebo)

Active, not recruiting
  • Acute Myeloid Leukemia
  • La Jolla, California
  • +69 more
Apr 5, 2022

Acute Myeloid Leukemia Trial in United States (Sapacitabine, Arm A, Sapacitabine, Arm B, Sapacitabine, Arm C)

Completed
  • Acute Myeloid Leukemia
  • Sapacitabine, Arm A
  • +8 more
  • Birmingham, Alabama
  • +14 more
Mar 23, 2022